Low Dose Naltrexone 1.5 mg

Product Overview

Low Dose Naltrexone 1.5 mg is a prescription medication primarily utilized for its modulatory effects on the immune system and its potential to support certain neurological and inflammatory conditions. Unlike standard doses of naltrexone used for opioid or alcohol dependence, the low-dose formulation is administered in much smaller quantities and under medical supervision to achieve distinct therapeutic outcomes. LDN is increasingly studied for its immunomodulatory and anti-inflammatory properties, making it a unique option in specific clinical contexts.

How It Works

Naltrexone in low doses functions by transiently blocking opioid receptors, which triggers a compensatory increase in endorphin and enkephalin production. These endogenous opioids play a role in regulating immune function and reducing inflammatory responses. By subtly modulating the immune system, LDN may help restore balance in conditions characterized by immune dysregulation. Although the exact mechanisms are still under investigation, its safety profile and low dosage make it suitable for certain off-label therapeutic uses when supervised by a healthcare professional.

Uses / Indications

Low Dose Naltrexone 1.5 mg may be prescribed as part of a comprehensive treatment plan for conditions involving immune dysregulation or chronic inflammation. Some areas of medical interest include:

• Supporting immune system balance in autoimmune conditions

• Potential adjunct therapy for inflammatory or neuropathic disorders

• Research into neurological conditions with an inflammatory component

It is important to note that LDN is generally considered off-label for these indications and should only be used under the guidance of a qualified healthcare provider.

Composition

Each tablet of Low Dose Naltrexone 1.5 mg contains:

• Active Ingredient: Naltrexone Hydrochloride 1.5 mg

• Excipients: Inactive ingredients suitable for oral administration, ensuring stability and ease of use

The formulation is designed for oral administration and is available in a small-dose tablet form suitable for precise dosing.

Administration

Low Dose Naltrexone 1.5 mg is administered orally, typically once daily in the evening or as directed by a healthcare provider. Dosing schedules may vary based on individual patient needs and the clinical condition being addressed. Careful titration and medical supervision are essential to ensure efficacy and safety, and self-adjustment of dosage is strongly discouraged.

Storage Instructions

Store LDN tablets at room temperature, away from heat, moisture, and direct sunlight. Keep out of reach of children and pets. Ensure the medication is stored in its original container to maintain stability and prevent degradation.

Important Information / Warning

Low Dose Naltrexone 1.5 mg should only be used under the supervision of a licensed healthcare professional. Patients should inform their provider of any pre-existing conditions, including liver disorders, opioid use, or other medications, to avoid potential interactions. Common considerations include:

• Avoiding concurrent opioid use unless specifically guided by a physician

• Monitoring for side effects such as sleep disturbances, headaches, or gastrointestinal discomfort

• Regular follow-up with healthcare providers to assess efficacy and safety

For more information on the medical uses and safety profile of low-dose naltrexone, visit the National Center for Biotechnology Information (NCBI).